PhilipScheinMD

PubMed

• 14 citations
  Chemotherapy of large intestinal carcinoma. Current results and future prospects.
  Philip S. Schein, Daniel L. Kisner, John S. Macdonald> ;Cancer. 2006 Jun 28
• 19 citations
  Barriers to efficient development of cancer therapeutics.
  Philip S. Schein, Barbara Scheffler> ;Clinical Cancer Research. 2006 Jun 1
• 1 citations
  The role of the FDA in the national cancer program: friend or foe?
  Philip S. Schein, Barbara Scheffler, Stephen K. Carter> ;The Oncologist. 2003 Dec 1
• 18 citations
  Preclinical Evaluation of WR-151327: An Orally Active Chemotherapy Protector
  Dianna Green, Dennis Bensely, Philip S. Schein> ;Cancer Research. 1994 Feb 1
• 29 citations
  Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer.
  Elizabeth Poplin, Patricia LoRusso, Jacob J. Lokich, John J. Gullo, Philip D. Leming, Joseph J. Schulz, Stephen R. Veach, William McCulloch, Laurence H. Baker, Philip ...> ;Cancer Chemotherapy and Pharmacology. 1994 Jan 1
• 50 citations
  Amifostine-mediated protection of normal bone marrow from cytotoxic chemotherapy.
  Robert L. Capizzi, Barbara Scheffler, Philip S. Schein> ;Cancer. 1993 Dec 1
• 16 citations
  New protective agents for bone marrow in cancer therapy.
  William McCulloch, B. J. Scheffler, P. S. Schein> ;Cancer Investigation. 1991 Jan 1
• 1 citations
  New Sugar Mitomycin C Analogues: Preparation, Murine P388 Antitumor Activity, and Leukopenia Induction
  Talebian Abdolhossen, Dianna Green, Charles F. Hammer, Philip S. Schein> ;Journal of Pharmaceutical Sciences. 1990 Dec 1
• 1 citations
  Murine anti-tumor activity of new water soluble platinum(II) complexes with reduced toxicity.
  Talebian Abdolhossen, Dennis Bensely, Philip S. Schein, Dianna Green> ;Anti-Cancer Drug Design. 1990 Nov 1
• 1 citations
  Phase I study of oral spirogermanium.
  Jimmie Harvey, Molly McFadden, Frederick P. Smith, Lucien Joubert, Philip S. Schein> ;Investigational New Drugs. 1990 Feb 1
• 5 citations
  WR-2721: a chemotherapy and radiation-protective agent.
  Philip S. Schein> ;Cancer Investigation. 1990 Jan 1
• 3 citations
  6-Bis-(2-chloroethyl)amino-6-deoxy-D-galactopyranose Hydrochloride: Synthesis, Chemical Characterization, Murine P388 Antitumor Activity, and Bone Marrow Toxicity
  Philip S. Schein, Dianna Green, Charles F. Hammer, Talebian Abdolhossen> ;Journal of Pharmaceutical Sciences. 1989 Nov 1
• 224 citations
  Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry.
  J B Lesesne, N Rothschild, B Erickson, S Korec, R Sisk, J Keller, M Arbus, Paul V. Woolley, L Chiazze, Philip S. Schein> ;Journal of Clinical Oncology. 1989 Jun 1
• 3 citations
  Therapy of advanced gastric carcinoma. The Georgetown-Lombardi Cancer Center experience.
  Joseph Treat, Steven C. Falchuk, Paul V. Woolley, James D. Ahlgren, John R. Neefe, Frederick P. Smith, Philip S. Schein> ;American Journal of Clinical Oncology. 1989 Apr 1
• 38 citations
  Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy
  Mary S. McCabe, Frederick P. Smith, John S. Macdonald, Paul V. Woolley, Deborah E. Goldberg, Philip S. Schein> ;Investigational New Drugs. 1988 Sep 1
• FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the P...
  Ahlgren Jd, Frederick P. Smith, Cazap El, Estevez Ra, Marantz A, Woolley Pv, Wilcosky T, Stein J, Philip S. Schein> ;Cancer Treatment Reports. 1987 Apr 1
• 7 citations
  6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose Hydrochloride (C6-Galactose Mustard), a New Alkylating Agent with Reduced Bone Marrow Toxicity
  Philip S. Schein, Dianna Green, Stephen W. Dean, Eugene Mcpherson> ;Cancer Research. 1987 Feb 1
• 14 citations
  Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomach.
  Cazap El, C. Gisselbrecht, Frederick P. Smith, Estevez Ra, Alvarez Ca, Lagarde C, Hannois A, Ahmed S, Philip S. Schein, Woolley Pv> ;Cancer Treatment Reports. 1986 Jun 1
• 4 citations
  Antitumor Activity and Bone Marrow Toxicity of Aminoglucose Mustard Anticancer Agents in Mice
  J. Cantrell, Dianna Green, Philip S. Schein> ;Cancer Research. 1986 May 1
• 56 citations
  5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary.
  Richard M. Goldberg, Frederick P. Smith, W Ueno, Ahlgren Jd, Philip S. Schein> ;Journal of Clinical Oncology. 1986 Mar 1
• 47 citations
  Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion.
  S Korec, Philip S. Schein, Frederick P. Smith, John R. Neefe, Paul V. Woolley, Richard M. Goldberg, T M Phillips> ;Journal of Clinical Oncology. 1986 Feb 1
• 1 citations
  DNA repeat length in chromatin from murine bone marrow and L1210 leukaemia cells.
  S. W. Dean, K D Tew, A. E. Clark, P. S. Schein> ;British Journal of Cancer. 1985 Sep 1
• 3 citations
  Carcinoid carcinomatous meningitis
  Robert A. Nagourney, Robert Hedaya, Markku Linnoila, Philip S. Schein> ;Annals of Internal Medicine. 1985 Jun 1
• Chemotherapy and combined modality therapy for locally advanced and metastatic gastric carcinoma.
  Le Chevalier T, Smith FP, Harter WK, Schein PS> ;Semin. Oncol.. 1985-03-01
• 5 citations
  Selective inhibition of cardiac cyclic nucleotide phosphodiesterases by doxorubicin and daunorubicin.
  Joseph Law, Angelo Fumagalli, Philip S. Schein, Aquilur Rahman> ;Life Sciences. 1985 Feb 11
• Join now to see all

Journal Articles

• The Case for a New National Program for the Development of Cancer Therapeutics  
  Schein, P.S., J. Clin. Oncology, 1/1/2001
• Phase II Study of Trimetrexate, Fluorouracil, and Leucovorin for Advanced Colorectal Cancer  
  Blanke, C.D., Kasimis, B., Schein, P., Capizzi, R., Kurman, M, Journal of Clinical Oncology, 1/1/1997
• Use of Amifostine in Bone Marrow Purging  
  Cagnoni, P.J.; Jones, R.B.; Scott I.B.; Ross, M.; Hami, L.; Franklin, W.A.; Capizzi, R.L.; Schein, P.S.; Shpall, E.J., Seminars in Oncology, 1/1/1996
• Proteccion hematologica frente a la quimioterapie antineoplasica mediante la amifostina  
  Capizzi, R.L.; Scheffler, B.J.; Schein, P.S., Rev. Cancer, 1/1/1995
• Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer  
  Poplin, E.A.; LoRusso, P.D.O.; Lokich, J.J.; Gullo, J.J.; Leming, P.D.; Schultz, J.J.; Veach, S.R.; McCulloch, W.; Schein, P.S., Journal of Cancer Chemotherapy and Pharmacology, 1/1/1994
• Preclinical evaluation of WR-151327: An orally active chemotherapy protector  
  Green, D.; Bensely, D.; Schein, P., Cancer Research, 1/1/1994
• Organic thiophosphate WR-151327 suppresses expression of HIV in chronically infected cells  
  Kalebic, T.; Schein, P.S., AIDS Research and Human Retroviruses, 1/1/1994
• Amifostine (WR-2721) Shortens the Engraftment Period of 4-Hydroperoxychclophosphamide-Purged Bone Marrow in Breast Cancer Patients Receiving High-Dose Chemotherapy Wit...  
  Shpall, E.J.; Stemmer, S.M.; Hami, L.; Franklin, W.A.; Shaw, L.; Bonner, H.S.; Bearman, S.I.; Peters, W.P.; Bast, R.C.; McCulloch, W.; Capizzi, R.; Mitchell, E.; Schei..., Blood, 1/1/1994
• Gastrointestinal cancer: a global perspective  
  Schein, P.S., Gastrointestinal Oncology, 1/1/1992
• Gastric cancer: Approaches to adjuvant therapy  
  Schein, P.S., Gastrointestinal Oncology, 1/1/1992
• A Phase I Study of WR-2721 in combination with total body irradiation (TBI) in patients with refractory lymphoid malignancies  
  Coia, L.; Krigel, R.; Hanks, G.; Comis, R.; Algazy, K.; Peter, R.; McCulloch, W.; Schein, P.S., International Journal of Radiation Oncology Biology Physics, 1/1/1992
• Results of chemotherapy and radiation therapy protection trials with WR-2721  
  Schein, P.S., Cancer Investigation, 1/1/1992
• New protective agents for bone marrow in cancer therapy  
  McCulloch, W.; Scheffler, B.; Schein, P.S., Cancer Investigation, 1/1/1991
• Socioeconomic status and cancer survival Cancer and Leukemia Group B  
  Cella, D.F.; Orav, E.J.; Kornblith, A.B.; Holland, J.C.; Silberfarb, P.M.; Lee, K.W.; Comis, R.L.; Perry, M.; Cooper, R.; Maurer, L.H.; Hoth, D.F.; Perloff, M.; Bloomf..., Journal of Clinical Oncology, 1/1/1991
• The role of hexamethylmelamine in the management of ovarian cancer  
  Schein, P.S.; Scheffler, B.; McCulloch, W., Cancer Treatment Reviews, 1/1/1991
• Aspartato (1,2-cyclohexanediamine)platinum(II) complexes: Synthesis and characterization; effects of minor impurities on antitumor activity  
  Talebian, A.H.; Bensely, D.; Ghiorghis, A.; Hammer, C.F.; Schein, P.S.; Green, D., Inorganica Chimica Acta, 1/1/1991
• WR-2721: A unique chemotherapy and radiation therapy protective agent  
  Schein, P.S.; Scheffler, B.; McCulloch W:, Clin. Oncol, Proceedings of the Fourth Annual UCI Cancer Conference on Clinical Management of the Drug Resistant Cancer Patient: New Options in Clinical Oncology, 1/1/1990
• Synthesis and characterization of a series of water soluble amidomalonato(1R,2R-Cyclohexanediamine)platinum(II) complexes  
  Talebian, A.; Bensely, D.; Green, D.; Schein, P.S., J. Coordinat. Chem., 1/1/1990
• Hexamethylmelamine as a single second-line agent in ovarian cancer  
  Manetta, A.; MacNeill, C.; Lyter, J.A.; Scheffler, B.; Podczaski, E.S.; Larson, J.E.; Schein, P., Gynecologic Oncology, 1/1/1990
• A randomised trial comparing adjuvant fluorouracil, doxorubicin and mitomycin with no treatment in operable gastric cancer  
  Coombes, R.C.; Schein, P.S.; Chilvers, C.E.D.; Wils, J.; Bliss, J.M.; Beretta, G.; Rutten, A.; Amadori, D.; Cortes-Funes, H.; Villar-Grimalt, A.; McArdle, C.; Rauschec..., Journal of Clinical Oncology, 1/1/1990
• Murine antitumor activity and toxicity of water soluble platinum (II) complexes with reduced toxicity  
  Talebian, A.H.; Bensely, D.; Green, D.; Schein, P.S., Anticancer Drug Design, 1/1/1990
• New sugar mitomycin C analogues: Preparation, murine P388 antitumor activity, and leukopenia induction  
  Talebian, A.; Green, D.; Hammer, C.F.,; McPherson, E.; Schein, P.S., Journal of Pharmaceutical Sciences, 1/1/1990
• Synthesis and murine P388 antitumor activity of uridine mustard: A preliminary report  
  Talebian, A.; Schein, P.S.; Green, D., Nucleosides and Nucleotides, 1/1/1990
• Cancer-associated hemolytic-uremic syndrome: Analysis of 85 cases from a national registry  
  Lesesne, J.B.; Rothschild, N.; Erickson, B.; Korec, S.; Sisk, R.; Keller, J.; Arbus, M.; Woolley, P.V.; Chiazze, L.; Schein, P.S.; Neefe, J.R., Journal of Clinical Oncology, 1/1/1989
• Therapy of Advanced Gastric Carcinoma  
  Treat, J.; Falchuk, S.C.; Woolley, P.V.; Ahlgren J.D.; Neefe, J.R.; Smith, F.P.; Macdonald J.S.; Schein, P.S., American Journal of Clinical Oncology, 1/1/1989
• Join now to see all

Books/Book Chapters

• Supportive Care of the Cancer Patient 
  Chapter: Supportive care of non-hematologic complications of cytotoxic therapy 
  Page 42.0 - 73.0Veach, S.R.; Schein, P.S.Oxford University Press, Inc., New York1997
• Handbook of Chemotherapy in Clinical Oncology 
  Chapter: Altretamine 
  Page 233.0 - 235.0Schein, P.S., Mattucci, L.C.; McCulloch, W.Editors: E. Cvitkovic, J.P. Droz, J.P. Armand, S. Khoury.Scientific Communication International Ltd, Channel IslandsEdition 2nd,1994
• Medical Oncology: Basic Principles, Principles of patient management 
  Chapter: Principles of patient management 
  Page 225.0 - 227.0Schein, P.S.; Calabresi, P.Editors: Calabresi, P.; Schein, P.S..McGraw-HillEdition 2nd,1993
• Medical Oncology: Basic Principles, Principles of patient management 
  Chapter: Acute and late effects of cancer therapy and their management 
  Page 345.0 - 369.0Mitchell, E.P.; Glicksman, A.S.; Schein, P.S.Editors: Calabresi, P.; Schein, P.S..McGraw-HillEdition 2nd,1993
• Medical Oncology: Basic Principles, Principles of patient management 
  Chapter: Clinical evaluation of new anticancer agents 
  Page 371.0 - 382.0Carter, S.K.; Schein, P.S.Editors: Calabresi, P.; Schein, P.S..McGraw-HillEdition 2nd,1993
• Medical Oncology: Basic Principles, Specific Neoplasms 
  Chapter: Gastric Cancer 
  Page 671.0 - 690.0Schein, P.S.; Haller, D.G.Editors: Calabresi, P.; Schein, P.S..McGraw-HillEdition 2nd,1993
• Medicine For The Practicing Physician 
  Chapter: Carcinoma of the pancreas 
  Schein, P.S.Edition 3rd,1992
• The Chemotherapy Sourcebook 
  Chapter: Nitrosoureas 
  Page 384.0 - 397.0Mitchell, E.P.; Schein, P.S.Editors: M. C. Perry, T. S. Satterfield, J. W. Pine.Williams and Wilkins, Baltimore, MD1992
• Decision Making in Oncology 
  Schein, PSEditors: Scheins, PS.Decker1989
• Britannica International Encyclopedia 
  Chapter: Tumours 
  Schein, P.S.1988
• Liposomes as Drug Carriers 
  Chapter: Use of Liposomes in Cancer Chemotherapy 
  Page 381.0 - 400.0Rahman, A.; Schein, P.S.Editors: G. Gregoriadis.John Wiley and Sons, Ltd1988
• The 1987 Nordic Post-graduate Oncology Seminar 
  Chapter: Chemotherapy of Gastric Cancer. Upper GI Tract Cancer--Research Frontiers and Direction of Progress 
  Schein, PEditors: Larsolof Hafstrom.ACTA Chirurgica Scandinavica Supplementum1988
• Basic Science in Gastroenterology, Diseases of the Gut 
  Chapter: Therapy of Gastrointestinal Cancer 
  Page 321.0 - 328.0Greig, R.G.; Schein, P.S.Editors: J.M. Polak; S.R. Bloom; N.A. Wright; A.G. Butler.1986
• The Cancer Chemotherapy 8 
  Chapter: Endocrine tumors 
  Page 388.0 - 394.0Schein, P.S.; van der Hoeven, J.J.M.Elsevier Science1986
• Cecil's Textbook of Medine 
  Chapter: Tumor markers 
  Page 1075 - 1077Schein, PSEditors: Wyngarrden, JB and Smith, LH.Saunders1985
• Medical Oncology: Basic Principals and Clinical Management of Cancer 
  Chapter: Neoplasms of the Stomach 
  Page 806 - 827Schein, PS, Levin, BEditors: Calabresi, P, Schein, PS, Rosenberg, SA.Macmillan1985
• Cecil's Textbook of Medicine 
  Chapter: Biologic effects of Cancer 
  Page 1073 - 1074Schein, PS1985
• Clinical Trials in Cancer: Past Achievements and Future Prospects 
  Chapter: Trials in gastric and colorectal carcinoma 
  Page 439.0 - 459.0Schein, P.S.Academic Press1985
• Cecil's Textbook of Medicine 
  Chapter: Biologic effects of tumors 
  Page 1073. - 1074.Schein, P.S.Editors: J.B. Wyngaarden and L.H. Smith, Jr..W.B. Saunders, Philadelphia1985
• Cecil's Textbook of Medicine 
  Chapter: Tumor markers 
  Page 1075. - 1077.Schein, P.S.Editors: J.B. Wyngaarden and L.H. Smith, Jr..W.B. Saunders, Philadelphia1985
• Medical Oncology: Basic Principles and Clinical Management of Cancer 
  Chapter: Molecular and cell biology of cancer 
  Page 3.0 - 40.0Busch, H.; Tew, K.; Schein, P.Editors: Calabresi, P.; Schein, P.; Rosenberg, S..Macmillan1985
• Medical Oncology: Basic Principles and Clinical Management of Cancer 
  Chapter: Etiology of Cancer: Introduction 
  Page 61.0 - 62.0Schein, P.Editors: Calabresi, P.; Schein, P.; Rosenberg, S..Macmillan1985
• Medical Oncology: Basic Principles and Clinical Management of Cancer 
  Chapter: Paraneoplastic Phenomena: Tumor markers 
  Page 178.0 - 188.0Holyoke, D.; Schein, P.Editors: Calabresi, P.; Schein, P.; Rosenberg, S..Macmillan1985
• Medical Oncology: Basic Principles and Clinical Management of Cancer 
  Chapter: Clinical evaluation of new anticancer agents 
  Page 392.0 - 405.0Carter, S.; Schein, P.Editors: Calabresi, P.; Schein, P.; Rosenberg, S..Macmillan1985
• Medical Oncology: Basic Principles and Clinical Management of Cancer 
  Chapter: Acute and late effects of cancer therapy 
  Page 426.0 - 453.0Glicksman, A.; Schein, P.Editors: Calabresi, P.; Schein, P.; Rosenberg, S..Macmillan1985
• Join now to see all

Lectures

• Commencement Address 
  Rutgers/Camden School of Business - 1/1/1997
• Class of 1960 Scholars Lecture 
  Williams College, Williamstown, MA - 1/1/1994
• Clinica Independencia Conference 
  Buenos Aires, Argentina - 1/1/1993
• Department of Hematology Clinical Investigation Research Conference 
  MD Anderson Cancer Center, Houston, TX - 1/1/1993
• Chemotherapy Conference 
  Mt. Sinai School of Medicine, New York City, NY - 1/1/1991
• First Annual Rose Kline Memorial Lecture 
  1/1/1986
• Treatment - Related Cancer 
  1/1/1985
• George W. Waterman Cancer Dialogue 
  Brown University - 1/1/1983
• Annual John Walker Moore Lecture 
  School of Medicine, University of Louisville - 1/1/1983
• Wadsworth Memorial Lecture 
  Rush Medical College, Chicago, Illinois - 1/1/1982
• Carmen Bellow Memorial Lecture 
  Department of Medicine, Temple University - 1/1/1982
• Pfizer Lecture in Clinical Pharmacology 
  Baylor College of Medicine, Houston, Texas - 1/1/1981
• Third Fenmore Lecture in Oncology 
  Cedars Sinai Medical Center - 1/1/1981
• Pharmacology of Nitrosourea Anticancer Agents 
  Department of Medicine, University of Pennsylvania - 1/1/1979
• Management of Gastrointestinal Cancer 
  Stanford University - 1/1/1978
• Nitrosourea Antitumor Agents 
  Beth Israel Hospital, Boston - 1/1/1978
• Join now to see all